123 results on '"Mitlak, Bruce"'
Search Results
2. Validation of the Surrogate Threshold Effect for Change in Bone Mineral Density as a Surrogate Endpoint for Fracture Outcomes: The FNIH‐ASBMR SABRE Project
3. Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study.
4. Response rates for lumbar spine, total hip, and femoral neck bone mineral density in men treated with abaloparatide: results from the ATOM study.
5. Efficacy and Safety of Transdermal Abaloparatide in Postmenopausal Women with Osteoporosis: A Randomized Study
6. Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data
7. Effect of Abaloparatide on Bone Microarchitecture Assessed by Trabecular Bone Score in Women With Osteoporosis: Post Hoc Analysis of ACTIVE and ACTIVExtend
8. Structure-based design of selective, orally available salt-inducible kinase inhibitors that stimulate bone formation in mice
9. The Efficacy and Safety of Abaloparatide‐SC in Men With Osteoporosis: A Randomized Clinical Trial
10. Does Teriparatide Improve Femoral Neck Fracture Healing: Results From A Randomized Placebo-controlled Trial
11. Validation of the Surrogate Threshold Effect for Change in Bone Mineral Density as a Surrogate Endpoint for Fracture Outcomes: The FNIH‐ASBMR SABRE Project
12. Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With Osteoporosis
13. Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice
14. Erratum for Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study
15. Validation of the Surrogate Threshold Effect for Change in Bone Mineral Density as a Surrogate Endpoint for Fracture Outcomes: The FNIH‐ASBMR SABRE Project.
16. Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analysis From the ACTIVE Phase 3 Trial
17. Response rates for hip, femoral neck, and lumbar spine bone mineral density in patients treated with abaloparatide followed by alendronate: Results from phase 3 ACTIVExtend
18. Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis
19. Pharmacogenomics in Endocrinology
20. THE REDUCED RISK OF NEW VERTEBRAL FRACTURE PERSISTS FOR UP TO 18 MONTHS FOLLOWING TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH RECOMBINANT HUMAN PARATHYROID HORMONE (1-34).
21. OR03-1 The Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis
22. OR03-2 Different Effects of Abaloparatide and h-PTH(1-34) on Osteoclastogenesis and Bone Resorption
23. Treatment‐Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Antiresorptive Drugs: Proportion of Treatment Effect Explained.
24. ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
25. Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis
26. The Effect of Discontinuing Treatment With Blosozumab: Follow‐up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density
27. A Randomized, Double‐Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density
28. Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women
29. Teriparatide for acceleration of fracture repair in humans: A prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures
30. Sequential effects of chronic human PTH (1-84) treatment of estrogen-deficiency osteopenia in the rat
31. Asymptomatic primary hyperparathyroidism
32. Intermittent administration of bovine PTH-(1-34) increases serum 1,25-dihydroxyvitamin D concentrations and spinal bone density in senile (23 month) rats
33. Effects of Teriparatide and Alendronate on Vertebral Strength as Assessed by Finite Element Modeling of QCT Scans in Women With Osteoporosis
34. Osteosarcoma and Teriparatide?
35. Sustained Nonvertebral Fragility Fracture Risk Reduction After Discontinuation of Teriparatide Treatment
36. Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure
37. The Skeletal Response to Teriparatide Is Largely Independent of Age, Initial Bone Mineral Density, and Prevalent Vertebral Fractures in Postmenopausal Women With Osteoporosis
38. Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene Therapy
39. Comment on Lack of Effect of Raloxifene on Coronary Artery Atherosclerosis of Postmenopausal Monkeys
40. The effect of systemically administered PDGF‐BB on the rodent skeleton
41. Accuracy, precision, and utility of spine and whole-skeleton mineral measurements by dxa in rats
42. Is Diabetes Mellitus a Heart Disease Equivalent in Women?: Results From an International Study of Postmenopausal Women in the Raloxifene Use for the Heart (RUTH) Trial.
43. Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women.
44. Teriparatide for Acceleration of Fracture Repair in Humans: A Prospective, Randomized, Double-Blind Study of 102 Postmenopausal Women With Distal Radial Fractures.
45. Pamidronate Reduces PTH‐mediated bone loss in a gene transfer model of hyperparathyroidism in rats
46. Sequential effects of chronic human PTH (1-84) treatment of estrogen-deficiency osteopenia in the rat.
47. Accuracy, precision, and utility of spine and whole-skeleton mineral measurements by dxa in rats.
48. Intermittent administration of bovine PTH-(1-34) increases serum 1,25-dihydroxyvitamin D concentrations and spinal bone density in senile (23 month) rats.
49. Asymptomatic primary hyperparathyroidism.
50. ERRATUMERRATUM for "Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis".
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.